British cannabis-making firm launched by 'Dr Pot' sold for £5.3bn
Reading now: 539
mirror.co.ukA British cannabis tycoon, dubbed 'Dr Pot' was this week celebrating a £5.3 billion windfall after selling up the company to an Irish firm.
Drugs company GW Pharmaceuticals has been snapped up by Irish peer Jazz Pharmaceuticals in a deal said to be worth $7.2bn. The deal was revealed yesterday with an announcement to shareholders in the New York-listed GW.
Following the news it was approved unanimously by directors on both boards, and will see Jazz pay 200 dollars per share in cash, as well as 20 dollars in its own shares.
GW is known for developing medicines from cannabis. It is the first company to be given approval by US authorities for a cannabidiol therapy used for treating seizures in both children and adults.
Read more on mirror.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
